CLPT · Categories · Form 4

CLPT - SEC Form 4 insider transactions

ClearPoint Neuro Inc. (CLPT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CLPT

• 29d
  SEC Form 4 filed by Fletcher R John

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 29d
  SEC Form 4 filed by Girin Pascal E R

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 29d
  SEC Form 4 filed by Richards Timothy T.

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 42d
  SEC Form 4 filed by Burnett Joseph

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 46d
  Chief Financial Officer D'Alessandro Danilo covered exercise/tax liability with 16,601 shares and converted options into 32,627 shares, increasing direct ownership by 18% to 102,684 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 46d
  CEO and President Burnett Joseph converted options into 84,829 shares and covered exercise/tax liability with 43,161 shares, increasing direct ownership by 77% to 95,900 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 46d
  Chief Business Officer Stigall L. Jeremy converted options into 30,995 shares and covered exercise/tax liability with 15,151 shares, increasing direct ownership by 17% to 108,482 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 46d
  Chief Operating Officer Sabra Mazin converted options into 26,101 shares and covered exercise/tax liability with 13,281 shares, increasing direct ownership by 24% to 67,343 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 49d
  Chief Financial Officer D'Alessandro Danilo converted options into 4,145 shares and covered exercise/tax liability with 2,109 shares, increasing direct ownership by 2% to 86,658 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 49d
  Chief Business Officer Stigall L. Jeremy converted options into 8,291 shares and covered exercise/tax liability with 3,224 shares, increasing direct ownership by 6% to 92,638 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 52d
  SEC Form 4 filed by ClearPoint Neuro Inc.

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 52d
  SEC Form 4 filed by ClearPoint Neuro Inc.

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 52d
  SEC Form 4 filed by ClearPoint Neuro Inc.

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 52d
  Chief Financial Officer D'Alessandro Danilo converted options into 18,765 shares and covered exercise/tax liability with 9,548 shares, increasing direct ownership by 12% to 84,622 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 56d
  CEO and President Burnett Joseph converted options into 26,568 shares and covered exercise/tax liability with 9,533 shares, increasing direct ownership by 136% to 29,534 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 56d
  Chief Financial Officer D'Alessandro Danilo converted options into 10,332 shares and covered exercise/tax liability with 5,257 shares, increasing direct ownership by 7% to 75,405 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 56d
  Chief Business Officer Stigall L. Jeremy converted options into 8,856 shares and covered exercise/tax liability with 4,506 shares, increasing direct ownership by 6% to 76,706 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 56d
  Chief Operating Officer Sabra Mazin converted options into 6,642 shares and covered exercise/tax liability with 3,380 shares, increasing direct ownership by 7% to 47,732 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 64d
  CEO and President Burnett Joseph sold $302,657 worth of shares (19,951 units at $15.17) (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 71d
  SEC Form 4 filed by Chief Operating Officer Sabra Mazin

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 71d
  SEC Form 4 filed by Chief Business Officer Stigall L. Jeremy

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 71d
  SEC Form 4 filed by Chief Financial Officer D'Alessandro Danilo

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 71d
  SEC Form 4 filed by CEO and President Burnett Joseph

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 93d
  CEO and President Burnett Joseph sold $45,823 worth of shares (2,943 units at $15.57) (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 107d
  CEO and President Burnett Joseph sold $322,400 worth of shares (20,000 units at $16.12) and exercised 20,000 shares at a strike of $2.50 (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 115d
  Chief Business Officer Stigall L. Jeremy was granted 1 shares, increasing direct ownership by 0.00% to 72,356 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 115d
  Chief Operating Officer Sabra Mazin was granted 386 shares, increasing direct ownership by 0.88% to 44,470 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 115d
  Chief Financial Officer D'Alessandro Danilo was granted 407 shares, increasing direct ownership by 0.58% to 70,330 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 115d
  CEO and President Burnett Joseph was granted 254 shares, increasing direct ownership by 2% to 11,565 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 115d
  Director Richards Timothy T. was granted 884 shares, increasing direct ownership by 1% to 79,754 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 115d
  Director Girin Pascal E R was granted 502 shares, increasing direct ownership by 0.52% to 97,451 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 115d
  Director Fletcher R John was granted 422 shares, increasing direct ownership by 0.36% to 116,662 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 156d
  Chief Financial Officer D'Alessandro Danilo exercised 3,555 shares at a strike of $8.10, increasing direct ownership by 5% to 69,923 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 199d
  CEO and President Burnett Joseph sold $714,021 worth of shares (26,463 units at $26.98) (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 199d
  Chief Operating Officer Sabra Mazin covered exercise/tax liability with 7,480 shares, decreasing direct ownership by 15% to 44,084 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 210d
  Director Fletcher R John was granted 265 shares, increasing direct ownership by 0.23% to 116,240 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 210d
  Director Girin Pascal E R was granted 315 shares, increasing direct ownership by 0.33% to 96,949 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 210d
  Director Richards Timothy T. was granted 555 shares, increasing direct ownership by 0.71% to 78,870 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 303d
  Chief Financial Officer D'Alessandro Danilo was granted 376 shares, increasing direct ownership by 0.57% to 66,368 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 303d
  Chief Business Officer Stigall L. Jeremy was granted 1,608 shares, increasing direct ownership by 2% to 72,355 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 303d
  Chief Operating Officer Sabra Mazin was granted 361 shares, increasing direct ownership by 0.71% to 51,564 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 303d
  CEO and President Burnett Joseph was granted 1,424 shares, increasing direct ownership by 14% to 11,311 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 303d
  Director Richards Timothy T. was granted 934 shares, increasing direct ownership by 1% to 78,315 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 303d
  Director Girin Pascal E R was granted 523 shares, increasing direct ownership by 0.54% to 96,634 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 303d
  Director Fletcher R John was granted 484 shares, increasing direct ownership by 0.42% to 115,975 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 322d
  Director Richards Timothy T. sold $132,800 worth of shares (10,000 units at $13.28), decreasing direct ownership by 11% to 77,381 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 322d
  Chief Financial Officer D'Alessandro Danilo covered exercise/tax liability with 4,754 shares, decreasing direct ownership by 7% to 65,992 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 322d
  Chief Business Officer Stigall L. Jeremy covered exercise/tax liability with 3,561 shares, decreasing direct ownership by 5% to 70,747 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 322d
  CEO and President Burnett Joseph covered exercise/tax liability with 15,476 shares, decreasing direct ownership by 61% to 9,887 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 323d
  CEO and President Burnett Joseph sold $282,373 worth of shares (21,247 units at $13.29) (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 330d
  Director Fallon Lynnette C sold $128,226 worth of shares (10,200 units at $12.57), decreasing direct ownership by 20% to 40,901 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 342d
  SEC Form 4 filed by Director Fallon Lynnette C

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 342d
  SEC Form 4 filed by Director Fletcher R John

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 342d
  SEC Form 4 filed by Director Girin Pascal E R

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 342d
  SEC Form 4 filed by Director Johnson B Kristine

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 342d
  SEC Form 4 filed by Director Klein Matthew B.

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 342d
  SEC Form 4 filed by Director Liau Linda M.

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 342d
  SEC Form 4 filed by Director Richards Timothy T.

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 347d
  Director Girin Pascal E R converted options into 21,093 shares, increasing direct ownership by 28% to 96,111 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)
• 347d
  Director Fletcher R John converted options into 21,093 shares, increasing direct ownership by 22% to 115,491 units (SEC Form 4)

  4 - ClearPoint Neuro, Inc. (0001285550) (Issuer)

Other CLPT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends